Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Islet Interleukin-1β Immunoreactivity Is an Early Feature of Cystic Fibrosis That May Contribute to β-Cell Failure
Rebecca L. Hull, Ronald L. Gibson, Sharon McNamara, et al.
Diabetes Care (2018) Vol. 41, Iss. 4, pp. 823-830
Open Access | Times Cited: 63

Showing 1-25 of 63 citing articles:

Pancreatic endocrine and exocrine signaling and crosstalk in physiological and pathological status
Chenglin Hu, Yuan Chen, Xinpeng Yin, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 2
Cystic fibrosis related diabetes: Pathophysiology, screening and diagnosis
Andrea Granados, Christine L. Chan, Katie Larson Ode, et al.
Journal of Cystic Fibrosis (2019) Vol. 18, pp. S3-S9
Open Access | Times Cited: 125
Islet Hormone and Incretin Secretion in Cystic Fibrosis after Four Months of Ivacaftor Therapy
Andrea Kelly, Diva D. De León, Saba Sheikh, et al.
American Journal of Respiratory and Critical Care Medicine (2018) Vol. 199, Iss. 3, pp. 342-351
Open Access | Times Cited: 89
The Human Islet: Mini-Organ With Mega-Impact
John T. Walker, Diane C. Saunders, Marcela Briššová, et al.
Endocrine Reviews (2021) Vol. 42, Iss. 5, pp. 605-657
Open Access | Times Cited: 67
ISPAD Clinical Practice Consensus Guidelines 2022: Management of cystic fibrosis‐related diabetes in children and adolescents
Katie Larson Ode, Manfred Ballman, Alberto Battezzati, et al.
Pediatric Diabetes (2022) Vol. 23, Iss. 8, pp. 1212-1228
Open Access | Times Cited: 33
Short-Term Effects of Elexacaftor/Tezacaftor/Ivacaftor Combination on Glucose Tolerance in Young People With Cystic Fibrosis—An Observational Pilot Study
Insa Korten, Elisabeth Kieninger, Linn Krueger, et al.
Frontiers in Pediatrics (2022) Vol. 10
Open Access | Times Cited: 29
Survival in a bad neighborhood: pancreatic islets in cystic fibrosis
Andrew W. Norris, Katie Larson Ode, Lina Merjaneh, et al.
Journal of Endocrinology (2019) Vol. 241, Iss. 1, pp. R35-R50
Open Access | Times Cited: 44
A tale of two pancreases: exocrine pathology and endocrine dysfunction
Michael R. Rickels, Andrew W. Norris, Rebecca L. Hull
Diabetologia (2020) Vol. 63, Iss. 10, pp. 2030-2039
Open Access | Times Cited: 43
Cystic fibrosis-related diabetes and lung disease: an update
Bernadette Prentice, Adam Jaffé, Shihab A. Hameed, et al.
European Respiratory Review (2021) Vol. 30, Iss. 159, pp. 200293-200293
Open Access | Times Cited: 41
The β Cell in Diabetes: Integrating Biomarkers With Functional Measures
Steven E. Kahn, Yi‐Chun Chen, Nathalie Esser, et al.
Endocrine Reviews (2021) Vol. 42, Iss. 5, pp. 528-583
Open Access | Times Cited: 38
New Concepts in the Pathogenesis of Cystic Fibrosis–Related Diabetes
Amir Moheet, Antoinette Moran
The Journal of Clinical Endocrinology & Metabolism (2022) Vol. 107, Iss. 6, pp. 1503-1509
Open Access | Times Cited: 25
Cystic Fibrosis–Related Diabetes: Pathophysiology and Therapeutic Challenges
R.C. Kelsey, Fiona N. Manderson Koivula, Neville H. McClenaghan, et al.
Clinical Medicine Insights Endocrinology and Diabetes (2019) Vol. 12
Open Access | Times Cited: 42
The role of modulators in cystic fibrosis related diabetes
Lina Merjaneh, S. N. Hasan, Nader Kasim, et al.
Journal of Clinical & Translational Endocrinology (2021) Vol. 27, pp. 100286-100286
Open Access | Times Cited: 31
Effect of Sitagliptin on Islet Function in Pancreatic Insufficient Cystic Fibrosis With Abnormal Glucose Tolerance
Andrea Kelly, Saba Sheikh, Darko Stefanovski, et al.
The Journal of Clinical Endocrinology & Metabolism (2021) Vol. 106, Iss. 9, pp. 2617-2634
Open Access | Times Cited: 25
The Impact of Pancreatic Exocrine Diseases on the β-Cell and Glucose Metabolism—A Review with Currently Available Evidence
Marina Ciochina, Daniel Vasile Balaban, George Mănucu, et al.
Biomolecules (2022) Vol. 12, Iss. 5, pp. 618-618
Open Access | Times Cited: 17
Cystic Fibrosis–Related Diabetes Workshop: Research Priorities Spanning Disease Pathophysiology, Diagnosis, and Outcomes
Melissa S. Putman, Andrew W. Norris, Rebecca L. Hull, et al.
Diabetes Care (2023) Vol. 46, Iss. 6, pp. 1112-1123
Open Access | Times Cited: 10
Curcumin-mediated NRF2 induction limits inflammatory damage in, preclinical models of cystic fibrosis
Stephen Adonai Leon‐Icaza, Maxence Frétaud, Sarahdja Cornélie, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 186, pp. 117957-117957
Open Access
Pharmacological inhibition of tyrosine protein-kinase 2 reduces islet inflammation and delays type 1 diabetes onset in mice
Farooq Syed, Olivia Ballew, Chih‐Chun Lee, et al.
EBioMedicine (2025), pp. 105734-105734
Open Access
When Two Worlds Collide: Navigating Diabetes in Cystic Fibrosis
Wisal Ahmad, Jansher Khan, Ahmad J Hashmat, et al.
Cureus (2025)
Open Access
20 years of the Montreal Cystic Fibrosis Related Diabetes Screening Cohort: key insights
Laure Alexandre‐Heymann, Valérie Boudreau, Dean Lim, et al.
European Respiratory Review (2025) Vol. 34, Iss. 176, pp. 240220-240220
Open Access
Heterogeneity of Diabetes: β-Cells, Phenotypes, and Precision Medicine: Proceedings of an International Symposium of the Canadian Institutes of Health Research’s Institute of Nutrition, Metabolism and Diabetes and the U.S. National Institutes of Health’s National Institute of Diabetes and Digestive and Kidney Diseases
William T. Cefalu, Dana K. Andersen, Guillermo Arreaza-Rubín, et al.
Diabetes Care (2021) Vol. 45, Iss. 1, pp. 3-22
Open Access | Times Cited: 23
Cystic Fibrosis-Related Diabetes (CFRD): Overview of Associated Genetic Factors
F Iafusco, Giovanna Maione, Francesco Maria Rosanio, et al.
Diagnostics (2021) Vol. 11, Iss. 3, pp. 572-572
Open Access | Times Cited: 21
The Potential Causes of Cystic Fibrosis-Related Diabetes
Lise Coderre, Lyna Debieche, J. R. Plourde, et al.
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 21
Interorgan crosstalk in pancreatic islet function and pathology
Ronald M. Evans, Zong Wei
FEBS Letters (2022) Vol. 596, Iss. 5, pp. 607-619
Open Access | Times Cited: 15
Cystic Fibrosis–Related Diabetes Workshop: Research Priorities Spanning Disease Pathophysiology, Diagnosis, and Outcomes
Melissa S. Putman, Andrew W. Norris, Rebecca L. Hull, et al.
Diabetes (2023) Vol. 72, Iss. 6, pp. 677-689
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top